MedWellAI, Inc. (MWAI) stock
MWAIOTCFinance ServicesFiscal year ends June 30
$0.20−0.12 (-37.50%)
Close on Oct 19, 2026Market cap –P/E –Yield –
MedWellAI EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
MedWellAI's EPS for the twelve months ending Jun 30, 2024 was -$2.72. For fiscal 2024 it was -$2.72. The highest annual figure on record is -$2.50 in fiscal 2020.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | -$2.72 | – |
| FY2023 | Jun 30, 2023 | -$11.98 | – |
| FY2021 | Jun 30, 2021 | -$20.00 | – |
| FY2020 | Jun 30, 2020 | -$2.50 | – |
| FY2019 | Jun 30, 2019 | -$87.50 | – |
| FY2018 | Jun 30, 2018 | -$83.75 | – |
| FY2012 | Mar 31, 2012 | -$25.00 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$0.10 | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$0.13 | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$0.47 | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $0.01 | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$0.13 | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$0.88 | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$0.70 | – |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $0.00 | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$0.89 | – |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$0.13 | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $0.00 | – |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $0.00 | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -$3.76 | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$13.75 | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $0.00 | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $0.00 | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -$1.25 | -200.0% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -$1.25 | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $0.00 | – |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | -$6.25 | – |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $1.25 | – |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | -$22.50 | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | -$64.58 | -743.2% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | -$1.25 | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | -$15.00 | – |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $0.00 | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $10.04 | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -$12.03 | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -$34.87 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?